Viewing nowCombinationJardiance Duo Tablet 12.5/1000 milligrams
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 201600390 · Approved 2016.01.21 · Insurance code 653501520
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in the improvement of blood sugar control in adult patients with type 2 diabetes who are using empagliflozin and metformin together, in conjunction with diet and exercise regimen. Particularly in adult patients with type 2 diabetes where blood sugar is not adequately controlled, and who have cardiovascular disease, caution regarding the occurrence of cardiovascular events is required; therefore, it is important to refer to the guidelines from a specialist. This medication effectively controls blood sugar and helps in the overall health management of the patient.
The recommended dose of this medication is 1 tablet per dose, 2 times daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg 2 times daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If a dose of this medication is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, given as 500 mg 2 times daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, discontinue this medication immediately (see Precautions for Use 2. Patients in Whom This Medication Is Contraindicated, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication contains components that help lower blood sugar levels. However, there is a risk of a rare side effect called severe lactic acidosis, and if symptoms occur, immediate consultation with healthcare professionals is necessary. There may be an increased risk of hypoglycemia when used in conjunction with other diabetes treatments. This medication should not be used in patients with severely impaired kidney function, acute kidney issues, severe infections, heart failure, or acute myocardial infarction. If undergoing tests using iodinated contrast agents, this medication should be discontinued for a period before and after the examination. It is safest for pregnant women or those who may become pregnant, as well as nursing mothers, not to take this medication. Elderly patients or those with slightly impaired kidney function should regularly monitor their kidney function and adjust the dosage accordingly. There may be side effects such as gastrointestinal disturbances, urinary tract infections, genital infections, increased urination, hypoglycemia, and it's important to inform healthcare professionals if symptoms occur. Patients at risk of fluid loss should be cautious with fluid intake to prevent dehydration, and may temporarily discontinue the medication if necessary. It is also advised to avoid alcohol consumption during the course of this medication, and if any unusual symptoms or discomfort occur, immediate consultation with healthcare professionals is necessary. Additionally, this medication may interact with certain medications, so it is important to inform if there are other medications being taken. Finally, this medication is not recommended for children or adolescents under the age of 18.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
Brownish-purple, bilaterally convex, oval film-coated tablet
60 tablets/box [10 tablets/PTP × 6 packs]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.